Sampled Announces a $46,000 Spatial Services Grant in Partnership with 10x Genomics

Research Opportunity to Use the 10x Genomics Xenium Platform for Spatially Resolved Transcriptomic Profiling and Cell Identity Analysis Piscataway, NJ – Sampled, an integrated analytical laboratory and biorepository, has partnered with 10x Genomics to offer a Spatial In Situ Gene Expression Services Grant, using the Xenium Prime 5K assay, for researchers across the United States. Spatial [...]

TheWell Bioscience Launches RocketCell™ Cell Viability Enhancer to Improve Cell Recovery, Survival, and Expansion Following Passaging, Cryopreservation, and Organoid Harvesting

Proprietary small-molecule formulation extends beyond conventional ROCK inhibitors to accelerate recovery and improve reproducibility in stem cell and organoid research. MONMOUTH JUNCTION, N.J. -- TheWell Bioscience, a leader in xeno-free 3D cell culture technologies, today announced the launch of RocketCell™ Cell Viability Enhancer (1000X), a next-generation cell recovery reagent engineered to maximize cell survival, metabolic [...]

Shimadzu Acquires Czech-Based TESCAN as a Wholly Owned Subsidiary Acquisition of Electron Microscopy Business Strengthens End-to-End Solutions in Analytical and Measuring Technologies

Shimadzu Corporation completed the acquisition on July 10 of all shares of Glass HoldCo s.r.o., which indirectly holds all shares of TESCAN GROUP, a.s. (“TESCAN”), a Europe-based pioneer in electron microscopy, thereby making TESCAN a wholly owned subsidiary. This transaction completes the share acquisition procedures for Glass HoldCo s.r.o. that Shimadzu announced on December 25, [...]

BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board

Dolsten Takes BenchSci's First-Ever Chairman Role as EMET Scales Across Global Biopharma TORONTO — BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective June 2026 — the first Chairman role in the company's history. [...]

Takara Bio USA, Inc. announces the retirement of Carol Lou, appoints Andrew Farmer as President and CEO

SAN JOSE, Calif. — Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc. ("Takara Bio"), today announced that Carol Lou will retire as President and Chief Executive Officer of Takara Bio USA on July 10 after more than two decades with the company. Andrew Farmer, D.Phil., who has served as Chief Scientific [...]

AkzoNobel accelerates R&D innovation with Albert Invent

Amsterdam, NL / Oakland, CA, USA — AkzoNobel, a global leader in paints and coatings, and Albert Invent, who is building the future of chemistry R&D, today announced an AI transformation partnership with AkzoNobel’s global R&D organization. AkzoNobel’s Digital Workbench initiative is designed to connect laboratory workflows, structure scientific data, and put modern AI tools [...]

BenchSci Names Former Pfizer R&D Chief Dr. Mikael Dolsten as Chairman of the Board

Dolsten Takes BenchSci's First-Ever Chairman Role as EMET Scales Across Global Biopharma TORONTO -- BenchSci, a leading provider of AI software for biopharma research and development, today announced the appointment of Dr. Mikael Dolsten, M.D., Ph.D., as Chairman of its Board of Directors, effective June 2026 — the first Chairman role in the company's history. [...]

Navinci and Lumito initiate pilot project – promising initial results from evaluation of combined technology

Uppsala, Sweden – Navinci Diagnostics AB (”Navinci”) today announces that the Company has initiated a pilot project together with Lumito AB (publ) (“Lumito”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis platform with Navinci’s in situ Proximity Ligation Technology (isPLA). By [...]

Bifrost Biosystems Pens Agreement with Illumina for Supply of Sequencing Chemistry for Optical Pooled Screening Platform

Agreement with leading life sciences company Illumina strengthens Bifrost's path to commercial deployment of next-generation optical pooled screening technology. BERKELEY, Calif. -- Bifrost Biosystems today announced that it has secured a commercial supply agreement with Illumina enabling integration of Illumina's industry-standard sequencing-by-synthesis (SBS) chemistry into its optical pooled screening (OPS) platform slated to be commercially available in early [...]

Navinci and Lumito initiate pilot project – promising initial results from evaluation of combined technology

Uppsala, Sweden — Navinci Diagnostics AB (”Navinci”) today announces that the Company has initiated a pilot project together with Lumito AB (publ) (“Lumito”) to evaluate the possibilities of combining the companies’ respective technologies within advanced tissue analysis. The pilot project aims to combine Lumito’s high-sensitivity image analysis platform with Navinci’s in situ Proximity Ligation Technology (isPLA). By [...]

Access IBO on Knowledge Center